We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$2.48B
Cap. Flow %
-27.43%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.09%
2 Consumer Discretionary 2.5%
3 Technology 1.62%
4 Financials 1.05%
5 Communication Services 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPX icon
326
PUT
Compass Therapeutics
CMPX
$344M
$6.48M 0.07%
+2,493,500
New +$5.14M
MKSI icon
327
CALL
MKS Inc
MKSI
$20.1B
$6.46M 0.07%
65,000
CCJ icon
328
CALL
Cameco
CCJ
$37.6B
$6.44M 0.07%
86,800
+61,500
+243% +$3.28M
DKNG icon
329
PUT
DraftKings
DKNG
$11.6B
$6.41M 0.07%
149,500
-30,500
-17% -$1.09M
QRVO icon
330
CALL
Qorvo
QRVO
$7.99B
$6.37M 0.07%
+75,000
New +$5.42M
KNSA icon
331
CALL
Kiniksa Pharmaceuticals
KNSA
$5.8B
$6.36M 0.07%
230,000
+200,000
+667% +$5.09M
GEO icon
332
CALL
The GEO Group
GEO
$4.13B
$6.36M 0.07%
265,700
-57,300
-18% -$1.57M
TSM icon
333
TSMC
TSM
$2.1T
$6.33M 0.07%
27,958
-16,542
-37% -$3.06M
ADMA icon
334
CALL
ADMA Biologics
ADMA
$1.96B
$6.33M 0.07%
347,600
+700
+0.2% +$14.3K
BMY icon
335
CALL
Bristol-Myers Squibb
BMY
$133B
$6.3M 0.07%
136,000
+56,000
+70% +$2.75M
H icon
336
PUT
Hyatt Hotels
H
$16.4B
$6.28M 0.07%
45,000
RGEN icon
337
PUT
Repligen
RGEN
$7.96B
$6.22M 0.07%
50,000
BDX icon
338
CALL
Becton Dickinson
BDX
$45.6B
$6.2M 0.07%
36,000
-151,800
-81% -$27.8M
SPR
339
CALL
DELISTED
Spirit AeroSystems
SPR
$6.19M 0.07%
162,200
+6,300
+4% +$226K
MTCH icon
340
CALL
Match Group
MTCH
$9.19B
$6.18M 0.07%
200,000
+70,600
+55% +$2.11M
WLY icon
341
John Wiley & Sons Class A
WLY
$2.65B
$6.13M 0.07%
+137,267
New +$5.78M
LVS icon
342
CALL
Las Vegas Sands
LVS
$31.7B
$6.09M 0.07%
140,000
-60,000
-30% -$2.33M
LNG icon
343
CALL
Cheniere Energy
LNG
$55.2B
$6.09M 0.07%
25,000
LNG icon
344
PUT
Cheniere Energy
LNG
$55.2B
$6.09M 0.07%
25,000
GXO icon
345
PUT
GXO Logistics
GXO
$5.77B
$6.09M 0.07%
125,000
TSEM icon
346
CALL
Tower Semiconductor
TSEM
$24.8B
$6.09M 0.07%
140,400
WBD icon
347
CALL
Warner Bros
WBD
$65.9B
$6.02M 0.07%
525,600
+343,100
+188% +$3.2M
CORT icon
348
CALL
Corcept Therapeutics
CORT
$12.4B
$6M 0.07%
81,700
-24,900
-23% -$1.81M
FLG
349
PUT
Flagstar Bank National Association
FLG
$5.93B
$6M 0.07%
565,600
+65,600
+13% +$749K
IREN icon
350
PUT
Iris Energy
IREN
$13.2B
$5.98M 0.07%
410,700
+179,400
+78% +$1.46M

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.